Neuropsychological assessment in a cohort of patients with Parkinson’s disease
Objective: To evaluate the cognitive profile in a cohort of patients with Parkinson's disease (PD) using a standardised battery. Background: Cognitive impairment is a great…Cerebrospinal fluid biomarkers in Parkinson’s disease and associated cognitive impairment
Objective: Our aim is to assess CSF levels of amyloid-β1-42 (Aβ1-42), T-Tau, threonine-181 phosphorilated tau (P-Tau) and α-synuclein (α-syn) as well as different ratios of…How does cognition affect reaching in Parkinson’s disease?
Objective: To explore differences in kinematic parameters of reach in those with Parkinson's disease (PD) classified into normal cognition (PD-NC), mild cognitive impairment (PD-MCI) and…Longterm outcome of cognition following subthalamic deep brain stimulation in Parkinson´s disease
Objective: Longterm, “real-life” assessment of cognitive evolution following subthalamic (STN) deep brain stimulation (DBS) in patients suffering from Parkinson´s disease. Background: Anecdotal reports have speculated…Grey matter atrophy associated with the progression of cognitive decline in Parkinson’s disease (PD)
Objective: To investigate the pattern of grey matter (GM) atrophy associated with cognitive decline in PD by use of voxel-based morphometry (VBM) analysis. Background: Loss…Attention and dopamine: Increased distractibility in Parkinson’s disease
Objective: To determine the interactions between dopamine, Working Memory(WM) and Attentional Control(AC) in Parkinson's disease(PD) patients. Background: WM impairment is common in PD. Studies have…Cognitive function and self-reported depressive symptoms in a population-based cohort to study non-motor-symptoms of Parkinson’s disease
Objective: To describe the relation of depressive symptoms with cognitive performance in our cohort at baseline and two-year follow-up. Background: Cognitive function (CF) is frequent…Impulse control disorder in Parkinson’s disease is not related to lower cognitive performance
Objective: To compare cognitive performance in patients with and without Impulse Control Disorders (ICD) according to MDS recommendations for Parkinson's disease (PD) Mild Cognitive Impairment…Is Apple Watch a new hope for patients with Parkinson’s disease?
Objective: To assess the capability of the smart watch (Apple Watch®) as a simple monitoring tool of motor fluctuation in patients with Parkinson's disease (PD).…Overlapping corticobasal syndromes: The many faces of the Armstrong criteria
Objective: To evaluate the prevalence and clinical presentation of corticobasal variants listed in the new Armstrong criteria, exploring their overlap with progressive supranuclear palsy (PSP),…
- « Previous Page
- 1
- …
- 68
- 69
- 70
- 71
- 72
- …
- 207
- Next Page »